[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications
Breast cancer is one of the most commonly diagnosed cancers and the leading cause of cancer mortality among women. Approximately 70-80 % of breast cancers are estrogen (ER) and/or progesterone receptor-positive, thus making endocrine therapy an important stage of treatment. Receptor expression in br...
Saved in:
Main Authors: | A. V. Parnas (Author), A. I. Pronin (Author), V. S. Ilyakov (Author), N. A. Meshcheryakova (Author), Z. Kh. Kamolova (Author), A. I. Mikhaylov (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
by: A. V. Parnas, et al.
Published: (2021) -
Osteomyelitis detected by 18F-FDG PET-CT
by: Alberto Martinez-Lorca, et al.
Published: (2024) -
Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome
by: L. Alix, et al.
Published: (2019) -
Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence
by: Elgin OZKAN, et al.
Published: (2016) -
The place of <sup>18</sup>F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report
by: N. Belfeki, et al.
Published: (2021)